PushKang
Latest round
- Series C
Last raised
- Oct 2022
Total raised
- $29M
Investors
- 11
About PushKang
, Ltd is a biotechnology company specializes in the development of microfluidic coagulation in-vitro diagnostic instrument. The company passed the EU ISO 13485 quality system certification in July 2016 and obtained the product registration certificate for the fully automated coagulation analyzer (MC500) in 2018 and the registration certificate for the fully automated chemiluminescent immunoassay analyzer and D-dimer in 2019. It has more than 300 employees and owns more than 70 patents, 26 of which are granted invention patents, including 7 US patents as of 2022. The company self-developed products include venous whole blood original tube on the machine testing system such as MC100 portable coagulation analyzer and MC510/550 automatic coagulation analyzer, centrifugal microfluidic fully automated POCT chemiluminescence immunoassay system, and centrifugal microfluidic biochemical POCT detection platform such as MS200 portable biochemical analyzer and MS100 portable biochemical analyzer. The company generates revenue from providing clinical test services.
Who invested in PushKang
11 investors across 5 rounds
See all investors in PushKang
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PushKang
Who invested in PushKang?
PushKang has 11 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PushKang raised?
PushKang has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did PushKang last raise money?
PushKang's most recent round on record is a Series C, in Oct 2022.
What does PushKang do?
, Ltd is a biotechnology company specializes in the development of microfluidic coagulation in-vitro diagnostic instrument.
Where is PushKang headquartered?
PushKang is headquartered in Shaoxing, China.
Which VCs invest in companies like PushKang?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at PushKang's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like PushKang? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.